Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia

This study has been completed.

Study NCT00046683 Information provided by Genzyme

First Received: October 1, 2002 Last Updated: July 28, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	November 2006
Estimated Primary Completion Date:	No date given